Reuters logo
BRIEF-Inotek files for preliminary proxy statement for proposed merger with Rocket Pharmaceuticals
October 12, 2017 / 9:40 PM / in 2 months

BRIEF-Inotek files for preliminary proxy statement for proposed merger with Rocket Pharmaceuticals

Oct 12 (Reuters) - Inotek Pharmaceuticals Corp

* Inotek Pharmaceuticals announces filing of preliminary proxy statement for proposed merger with clinical-stage gene therapy company, Rocket Pharmaceuticals

* Inotek Pharmaceuticals Corp - ‍additional first-in-human results from up to three programs expected in 2018​

* Inotek Pharmaceuticals Corp - ‍merger is expected to close in Q1 of 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below